Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.31 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.30 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.30 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.30 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31421228 | 0.89 | DPP4 (0.33) | DPP4GPR119NR1H2NR1H3ABHD6 | |
| SCHEMBL31420742 | 0.86 | GPR119 (0.43) | DPP4GPR119 | |
| SCHEMBL31377330 | 0.86 | GPR119 (0.42) | DPP4GPR119NR1H2NR1H3UCHL1 | |
| SCHEMBL31420706 | 0.85 | DPP4 (0.40) | DPP4NR1H2NR1H3USP30 | |
| SCHEMBL31420802 | 0.84 | DPP4 (0.34) | DPP4GPR119NR1H2NR1H3USP30 | |
| SCHEMBL31421112 | 0.83 | NR1H2 (0.35) | DPP4GPR119NR1H2NR1H3 | |
| SCHEMBL31421333 | 0.82 | NPC1 (0.39) | DPP4GPR119NR1H2NR1H3 | |
| SCHEMBL31421467 | 0.82 | TACR1 (0.35) | DPP4NR1H2NR1H3 | |
| SCHEMBL31420677 | 0.82 | SMN1; SMN2 (0.35) | DPP4NR1H2NR1H3 | |
| SCHEMBL31421033 | 0.82 | TACR1 (0.42) | DPP4NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2025064718-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | DPP4 4741/4885GPR119 3347/4885NR1H2 2741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.